Resources
Glossary
Key terms used across this blueprint. For architecture detail, start with LabOS Agentic Architecture.
Platform & agents
| Term | Definition |
|---|---|
| LabOS | Agentic lab operating system — five-agent mesh (Hypothesis, Design, Execution, QC/Validator, Learning) that produces the experimental graph. |
| Experimental graph | Typed, provenance-signed DAG of lab operations; every datapoint tied to the chain that produced it. |
| OmicsOS | Multiomics AI layer — WGS/WES, scRNA-seq, spatial, proteomics — feeding hypotheses into LabOS. |
| ClinicalBridge | Regulatory translation layer — CDSCO, FDA, TGA, PMDA dossiers and bridging packages. |
| Execution Broker | LabOS component routing experiment nodes to qualified CRO/cloud-lab partners via the capability registry. |
| Protocol IR | Typed intermediate representation for lab operations — stable contract between Design and Execution agents. |
| Capability registry | “npm for lab ops” — manifests of what each CRO/instrument supports, for smart routing. |
Discovery & data
| Term | Definition |
|---|---|
| DBTL | Design-Build-Test-Learn — closed-loop cycle compressed by agentic orchestration. |
| India Biomarker Atlas | Proprietary biomarker database on Apollo substrate — see dedicated page. |
| Discovery Sprint | Time-boxed, milestone-gated program (90 days to 18 months) powered by LabOS end-to-end. |
| CDx | Companion diagnostic — test paired with a therapeutic to identify patients likely to respond. |
| NAMs | New Approach Methodologies — organoids, organ-on-chip, 3D culture replacing animal testing. |
| PGx | Pharmacogenomics — how genetic variants affect drug response (e.g. CYP2C19, VKORC1 in Indian populations). |
Infrastructure & strategy
| Term | Definition |
|---|---|
| FAL | Fully Autonomous Lab — robotic wet-lab execution. We partner in Phase 1; own pods in Phase 2+. See Build vs Partner. |
| LIMS | Laboratory Information Management System — STARLIMS, LabWare, Benchling, etc. LabOS integrates as sidecar first. |
| BioHelix | Singapore APAC node — MiRXES i4.0 wet lab, Biopolis ecosystem, India–Singapore corridor. See BioHelix page. |
| DPDP Act 2023 | India Digital Personal Data Protection Act — governs patient data; drives sovereign model requirement. |
| Closed-loop discovery cycle | North Star unit: hypothesis → design → execute → validate insight. See KPIs. |